Related by context. All words. (Click for frequent words.) 59 Therapeutic Competitors Report 59 MBRX 58 YM Biosciences 58 Declares Dividend Quick Facts 57 Syntonix Pharmaceuticals 57 Aerie Pharmaceuticals 57 PHARMACEUTICALS 57 Guides FY# Quick Facts 57 Tyrian Diagnostics 57 Dynogen Pharmaceuticals 57 Psivida 57 Thewallstreetleader.com Profiles 56 Genetic Therapy 56 Valera Pharmaceuticals 56 Apricus Biosciences 56 Taglich Brothers Initiates Coverage 56 COVIDIEN 56 BioSepra 56 Merz Pharma GmbH 56 Graceway Pharmaceuticals LLC 56 DUSA Pharmaceuticals 56 Idenix Pharmaceuticals IDIX 56 Taligen Therapeutics 56 Myrexis Inc. 56 Cavitation Technologies 56 Proxy Biomedical 56 Novartis AG Basel Switzerland 56 Metabasis Therapeutics 56 Initiates Enrollment 56 THE HUMAN RESOURCE 56 ΞΕΝΗ ΔΗΜΟΣΙΕΥΣΗ ΑΝΑΚΟΙΝΩΣΗInfosys Finacle 55 Essentialis 55 Cara Therapeutics 55 CELGENE 55 Review Strategic Alternatives 55 Files IND 55 COMUNICADO DE 55 Theraputics 55 ELGX 55 NASDAQ GTCB 55 Therapeutic Competitors Companies 55 ACADIA Pharmaceuticals 55 GENZYME 55 MSD Biologics UK 55 Xanthus Pharmaceuticals Inc. 55 ICON plc 55 AVANT Immunotherapeutics 55 Oxford Genome Sciences 55 Licenses Novel 55 Osmetech Molecular Diagnostics 55 Announce Collaboration Agreement 55 Initiates Clinical Trial 55 Electrospinning 55 IPSEN 55 Marillion Pharmaceuticals 55 BIOPHARMA 55 Vion Pharmaceuticals 55 Vysis 55 Integra Lifesciences 55 Submits NDA 55 NASDAQ DCGN 55 Supergen 55 Alantos 55 Resolvyx Pharmaceuticals 55 Sign License Agreement 55 Myers Squibb 55 CONTINUES DOWN 55 BellBrook Labs 54 Ercole Biotech 54 Neose Technologies 54 NASDAQ SPPI 54 Omnia Biologics 54 Initiates Clinical Trials 54 3M Completes Acquisition 54 RDEA 54 H.B. Fuller 54 Fumapharm AG 54 Phamaceuticals 54 Lantibio 54 COMPLETES ACQUISITION OF 54 FLDM 54 Transcept Pharmaceuticals 54 DuNE 54 AviaraDx 54 PF # [002] 54 BLP# Liposome Vaccine 54 Microfluidics wholly owned 54 Tibotec Pharmaceuticals Ltd. 54 Biotherapies 54 Enters Into Licensing Agreement 54 NUEC 54 CYTC 54 ARCA Biopharma 54 ILSE 54 Therion Biologics 54 FY# Loss Narrows 54 QLTI 54 Restructures Operations 54 Panacea Pharmaceuticals 54 DOWNGRADE ALERT WATCH FOR 54 Announces Tentative Approval 54 Files Shelf Registration Statement 54 Instrumentation Laboratory 54 Catalyst Biosciences 54 Oxxon Therapeutics 54 Phusion Laboratories 54 Microwave Ablation System 54 Celera Genomics Group 54 EMD Biosciences Inc. 54 'S LOSSES 54 Nasdaq BIIB 54 NASDAQ VRUS 54 SYN X 54 MOMENTUM LOOKS TO CONTINUE 54 PerkinElmer Acquires 54 Sinks Lower 54 NEW YORKNY 54 Intertek Acquires 54 Xytis 54 Radiat 54 AUDIO PROVIDED BY 54 Completes Merger With 54 Embolic Protection 54 CONTINUES UP 54 PHARMACEUTICALS INC 54 ProMetic BioSciences 54 PDL BioPharma Inc 54 NASDAQ BSMD medical 54 Alpha Biologics 54 Gendux AB 53 THERAPEUTICS 53 Mersana Therapeutics Inc. 53 Astex Therapeutics Limited 53 Millenium Biologix 53 AltaRex 53 Receives Milestone Payment 53 Completes Patient Enrollment 53 Cabrellis 53 Trellis Bioscience 53 AION Diagnostics 53 Announces Cancellation 53 Kiadis 53 Transkaryotic Therapies TKTX 53 TSX CTI 53 DOWNGRADED ONE WEEK AGO 53 IART 53 STRONGLY ADVISES ALL 53 CRYO 53 R MSCRAMM 53 Prism Pharmaceuticals 53 Sign Licensing Agreement 53 X Ceptor Therapeutics 53 Biosante Pharmaceuticals 53 Tibotec BVBA 53 Nasdaq PARD 53 BFRM 53 BIOSCIENCE 53 ANNOUNCES APPOINTMENT OF 53 Bovie Medical 53 Locus Pharmaceuticals 53 CEPHALON 53 DRRX 53 THERAPEUTICS INC 53 Raven biotechnologies 53 ROSG 53 Modrenal R 53 CONTINUES LOWER 53 ABIO 53 IG HCR ;) CO 53 NASDAQ INFI 53 Memgen 53 Successfully Completes Tender Offer 53 Nasdaq TARG 53 Presents Preclinical Data 53 BIOTECHNOLOGY 53 SHARES SLIDING LOWER DOWN 53 OTCBB CHKT biotechnology 53 FoldRx Pharmaceuticals Inc. 53 Therapeutic Competitors companiesandmarkets.com adEgemonye 53 Diosynth RTP 53 Faircourt Asset Management 53 SRDX 53 ViRexx Medical 53 HIGHER ON #.#X ABOVE 53 Genome Therapeutics 53 Idera Pharmaceuticals 53 WeissComm Partners +#-#-#-# 53 Presents Positive 53 Cobra Biomanufacturing 53 ANNOUNCES RECORD 53 Achillion Pharma 53 CELANESE 53 ENZN 53 Biogen Nasdaq BIIB 53 SIX RO ROG 53 LifeCell Corporation 53 Gets FDA Clearance 53 Supernus Pharmaceuticals Inc. 53 Nasdaq PGNX 53 INTERACTIVE ENTERTAINMENT 53 Viron Therapeutics 53 HP Acthar r 53 Signet Laboratories 53 Announces Reverse Split 53 FOLLOWING LAST YEAR 53 DIAGNOSTICS 53 Novagen 53 Luveris R Ovidrel R 53 Bio Rad Labs 53 PHRM 53 Viralytics 53 Enters Into License Agreement 53 Sunshine Biopharma 53 TECHNOLOGY INC 53 Coley Pharmaceutical 53 Regeneron Pharma 53 Adamis Pharmaceuticals 53 Announces Licensing Agreement 53 REACHES INITIAL SUPPORT LEVEL 53 Epiphany Biosciences 53 Closes Merger 53 Adrian Hobden 53 Amends Agreement 53 MAX CAPITAL GROUP 53 Antigenics NASDAQ AGEN 53 MultiCell Technologies 53 PFIZER INC. 53 Astex Therapeutics 53 Lexicon Genetics Incorporated 53 SMMX 53 Given Outperform Rating 53 TRACON Pharmaceuticals 53 Announce Merger Agreement 53 FY# Loss Widens 53 BIOSCIENCES 53 Eurand Pharmaceuticals 53 ENDO PHARMACEUTICALS 53 Extends Collaboration 53 KEYWORD PHARMACEUTICAL 53 Completes Recapitalization 53 GTC NASDAQ GTCB 53 FDA APPROVES 53 VisEn Medical 53 Receives Approvable Letter 53 Shire NASDAQ SHPGY 53 Technol 52 Nasdaq THLD 52 Celera CRA 52 Lexicon Pharmaceuticals 52 Diomed Holdings 52 TRGT 52 Presents Positive Preclinical 52 GGS US 52 MEDICAL PHARMACEUTICAL 52 Aureon Laboratories 52 Oxis International 52 Hld 52 Orchid Biosciences 52 Peakdale Molecular 52 Receives Fast Track 52 Explores Strategic Alternatives 52 PSDV 52 Osmetech plc 52 DISTRIBUTION AGREEMENT WITH 52 Excaliard Pharmaceuticals 52 FGXI 52 KS Biomedix 52 TRADING LOWER ON #.#X 52 ARYX 52 CellMed 52 Sunesis Pharmaceuticals 52 Exploit collaboration 52 NOVARTIS 52 EMPLOYMENT SERVICES INDUSTRY 52 MOVING AVERAGE CROSSOVER ALERT 52 BIOGEN IDEC 52 Exploring Strategic Alternatives 52 Reversal Soon 52 DOV Pharmaceutical 52 DOVP 52 Receives CE Marking 52 LMNX 52 Nostrum Pharmaceuticals 52 CureDM 52 MLNM 52 DOV Pharmaceutical Inc. 52 Merck Sante sas 52 Agios Pharmaceuticals 52 Vicuron Pharmaceuticals 52 Announces FDA Clearance 52 NASDAQ DIGE 52 PHARMACEUTICALS INC. 52 MEDW 52 LLC Mgr 52 MYRX 52 Initiates Phase II 52 Curon Medical 52 Ciphergen Biosystems 52 Initiates Clinical 52 LXRP 52 FMC FMC 52 More PTI LKJ 52 Nasdaq AGEN 52 NVGN 52 OPi 52 Decas Botanical Synergies 52 Bearish MACD 52 Nasdaq IDIX 52 Nasdaq CYCC 52 NOVN 52 Martinsried Germany 52 RenaMed Biologics 52 OIL LTD 52 BOSTON SCIENTIFIC 52 Q4 Profit Decreases 52 EURX 52 DEVON ENERGY 52 Changes Ticker Symbol 52 Fibrocell Science Inc. 52 CONTINUES HIGHER 52 MacroMed 52 Biotherapeutics 52 Named Exclusive Distributor 52 MerLion Pharmaceuticals 52 Protein Polymer Technologies 52 Akers Biosciences 52 InNexus Biotechnology 52 Crit Rev 52 Oncothyreon Inc 52 Initiates Dosing 52 POLYMERS 52 ORD SHS 52 STOCK RISES 52 AEROPOSTALE 52 ENTREE GOLD 52 MicroCal 52 NASDAQ SHPGY 52 Pharmacopeia PCOP 52 THE TREND CONTINUES LOWER 52 CDXS 52 Q1 Adj 52 VentiRx Pharmaceuticals 52 Announce License Agreement 52 Nasdaq RIGL 52 Prima BioMed 52 InteKrin Therapeutics 52 Advanced Inhalation 52 Genvec 52 LORILLARD 52 Announces License Agreement 52 MBRK 52 Numatics 52 SHAREHOLDERS APPROVE 52 NewsBite Downgrade Puts Pressure 52 Completes Reverse Merger 52 Reports Preclinical Data 52 Cavit Sciences Inc. 52 Pharmanet 52 Inc Therapeutic Competitors 52 Prion Developmental Laboratories 52 Genisphere 52 Elan Pharma 52 Biocompatibles International 52 Indevus Pharmaceuticals 52 KOSN 52 Reiterates Strong 52 Ξένη δημοσίευση ΑΝΑΚΟΙΝΩΣΗNVQ Assessor 52 NYSE BDX 52 Attracting Bullish Investors 52 Covalon Technologies 52 SHARES FALL 52 CardioTech International 52 OLGX 52 Pernix Therapeutics 52 Conatus Pharmaceuticals 52 * vwd PRN 52 Guides FY# Update 52 ProChon Biotech Ltd. 52 Tibotec Virco 52 Nereus Pharmaceuticals 52 Alfa Wassermann 52 MTOR 52 RDYN 52 Explore Strategic Alternatives 52 Pipex Pharmaceuticals 52 LSE SHP.L 52 PERRIGO 52 Roche OTC RHHBY 52 Resolutions Passed 52 Q3 Adj 52 Endures Analyst Downgrade 52 Exploratory Clinical 52 Selenia Dimensions System 52 Guided Therapeutics Inc. 52 ISOCOUNTRY3 52 BSMD 52 INFOSYS TECHNOLOGIES 52 Nasdaq BSTE 52 Arqule 52 Medicis Pharmaceutical Corp 52 Q2 Profit Climbs 52 Herborium Group 52 Proc Am Soc 52 Announces Record Date 52 Sensipar ® 52 Onconova Therapeutics Inc. 52 LGND 52 Xceed Molecular 52 Senesco Technologies 52 Nasdaq ANPI 52 Tokai Pharmaceuticals 52 Flamel Technologies 52 Medisorb ® 52 Announcement acc 52 AMEX CTE 52 Accera Inc. 52 Cyclacel Pharmaceuticals 52 ROTATEQ ® 52 Verisyse TM intraocular lenses 51 ACLARA BioSciences 51 Receives Orphan Drug Designation 51 Q1 Profit Decreases 51 AGREEMENTS SOURCE 51 Cima Labs 51 TriPath Oncology 51 Nasdaq ACHN 51 PRODUCTS INC. 51 PENNY STOCK ON 51 Lincluden Management 51 OSUR 51 Insmed Incorporated NASDAQ INSM 51 Zosano Pharma 51 CRGN 51 Tyco Intl 51 THER 51 MEDICAL SYSTEMS 51 Reveals Positive 51 Indevus Pharma 51 Intellipharmaceutics International 51 Expression Pathology 51 Paratek Pharmaceuticals Inc. 51 Alexion Pharma 51 Chiron Diagnostics 51 NYSE COV 51 AFFYMETRIX 51 PPD Nasdaq PPDI 51 BIOTECHNOLOGY SOURCE 51 COMPELLENT TECHNOLOGIES 51 Initiates Phase III 51 Enterix 51 Alimentary Health 51 Ironwood Pharmaceuticals Inc. 51 BPUR 51 VIAC 51 INTL INC 51 Oxford Nanopore Technologies 51 Pharmacueticals 51 NeuroMedix 51 DOWNTREND CALL 51 Javelin Pharmaceuticals 51 Announces Rebranding 51 Nasdaq AMGN 51 VICR 51 Source Victhom Human 51 ABBOTT LABORATORIES 51 Clinphone 51 Arete Therapeutics 51 Cytori Therapeutics Inc 51 Nasdaq PANC 51 WORLDWIDE INC. 51 Begins Clinical Trial 51 PXSL 51 Sets Record Date 51 Mng 51 Signs Merger Agreement 51 Luitpold Pharmaceuticals 51 Tocris 51 STOCK EXCHANGE ANNOUNCEMENT #.#.# 51 Announce Licensing Agreement 51 Daytradersdigest.com 51 InB Biotechnologies 51 EXPANDS ITS 51 Aldara ® 51 NASDAQ RNAI 51 Biochem 51 Cytec Industries Inc 51 CRXA 51 Hybridon 51 Inflazyme Pharmaceuticals 51 CLZR 51 Emisphere Technologies 51 DARA logo 51 Obtains License 51 Completes Tender Offer 51 Psoriasis Drug 51 Epoch Biosciences 51 Q2 Adj 51 INTERNATIONAL HOLDINGS INC. 51 Thallion Pharmaceuticals 51 TO AVOID PREGNANCY WHILE 51 Theravance THRX 51 provides RevColor RevDisplay 51 Chroma Therapeutics 51 Balchem Corporation 51 :/ finance.yahoo.com q 51 Barrier Therapeutics Inc. 51 INFI 51 RONKONKOMA NY BUSINESS WIRE 51 Progenics Pharmaceuticals 51 Q4 Profit Climbs 51 BIOM 51 BMXP 51 EÜ 51 Engages CHF Investor Relations 51 THE RUN DOWN 51 NKBP 51 Receives Stockholder Approval 51 Azur Pharma 51 Shareholders Approve Merger Agreement 51 Undisclosed Investors 51 Eyetech Pharmaceuticals 51 Orqis Medical 51 Iconix Pharmaceuticals 51 NOVAVAX 51 Hydra Biosciences 51 Announces Debt Settlement 51 Raven Biotechnologies 51 Progenics Pharmaceuticals Inc 51 VRNM 51 PHASE III 51 Dendritic Nanotechnologies Inc. 51 CNGL 51 ONYX Pharmaceuticals 51 Collagen Matrix 51 OMRIX Biopharmaceuticals 51 Synergy Pharmaceuticals 51 Anticancer Agent 51 FMC TECHNOLOGIES 51 CLDX 51 Receives Notice Regarding 51 ALTERA 51 PITNEY BOWES 51 Signs Purchase Agreement 51 Avila Therapeutics 51 Ichor Medical Systems 51 Obtains Exclusive License 51 CONFERENCE CALLS SOURCE 51 novel synthetic peptide 51 Aegerion Pharmaceuticals 51 Nasdaq AVNC 51 KRONOS WORLDWIDE 51 Genpharm 51 ARDM 51 NASDAQ ENMD 51 WEEK HIGH RECENTLY ECLIPSED 51 Transact Technologies 51 Enters Oversold Territory 51 Nippon Shokubai 51 Announce Definitive Agreement 51 HEALTHCARE SERVICES 51 Completes Reorganization 51 Criticare Systems 51 SOLVAY PHARMACEUTICALS 51 EXPLORATION LTD 51 REPORTS THIRD QUARTER 51 GeneThera Inc. 51 BioSpecifics Technologies 51 ANNOUNCES PARTNERSHIP WITH 51 Akorn Inc 51 Announces Divestiture 51 Systemic Delivery 51 Penwest Pharma 51 TekCel 51 SET TO PULLBACK AFTER 51 Alnara Pharmaceuticals 51 mins #.#secs A8 51 HELSINN 51 Compounder 51 Sanofi NYSE SNY 51 Hldgs Co 51 Neurobiological 51 SENO 51 Fumapharm 51 AMEX PTN 51 OncoGenex Pharmaceuticals 51 Ferguson HLS MBS 51 Piper Jaffray downgrades 51 Evaluate Strategic Alternatives 51 NPTN 51 NASDAQ AEZS 51 Decision Biomarkers 51 Restructures Debt 51 CALL VOLUME UP 51 GROUP THE TREND 51 Celltech Pharmaceuticals 51 Qiagen NASDAQ QGEN 51 Alligator Bioscience AB 51 ETEV 51 Tragara Pharmaceuticals Inc. 51 WYETH 51 Vivecon 51 AVERAGE VOLUME 51 Biotherapeutic 51 WR GRACE 51 TPPH 51 Protedyne 51 Merrimack Pharmaceuticals 51 CHECK POINT SOFTWARE TECHNOLOGIES 51 Pervasis Therapeutics Inc. 51 POWER CORPORATION 51 SHP.L 51 ANNUAL FINANCIAL REPORT 51 Durect Corporation 51 OTC RHHBY 51 Cornerstone BioPharma 51 DAIICHI 51 GeneOhm Sciences 51 Quark Biotech 51 Cl b 51 Announces Effective Date 51 Saegis Pharmaceuticals 51 Inflazyme 51 NASDAQ SGMO 51 Parametric Technology Corp 51 About Chemokine Therapeutics 51 Astron Clinica 51 KAI Pharmaceuticals Inc. 51 CDXC 51 NGSX 51 Announce Expiration 51 Increases Ownership 51 HONEYWELL INTERNATIONAL 51 Mersana Therapeutics 51 Amvescap PLC UK 51 Present Preclinical Data 51 OTCBB PYTO 51 STARFlex R 51 EPS ESTIMATES FOR 51 Announce Early Termination 51 OncoMethylome Sciences 51 Procyon Biopharma 51 Jumps Higher 51 WEBBOLT Petrochemicals 51 Amylin Pharma 51 Cantel Medical Corp 51 Revises FY# Outlook 51 DGAP Ad hoc 51 ASM INTERNATIONAL 51 CHANGES SOURCE 51 2 inhibitor CYT# 51 REPORTS FIRST QUARTER 51 Vaccinex 51 Nexeon MedSystems 51 Virco Mfg. Corporation 51 SMARTREND RESEARCH REPORT AVAILABLE 51 Put Volume Surges 51 OTCBB FCSC 51 Ascenta Therapeutics 51 Boosts Qtr 51 Advanced Refractive 51 Momenta Pharmaceuticals MNTA 51 Infinity Pharmaceuticals 51 TissueInformatics 51 TKPHF 51 OMRIX Biopharmaceuticals Inc. 51 SHARES CREEPING HIGHER UP 51 Cardica CRDC 51 QuatRx Pharmaceuticals 51 TASEKO MINES 51 Initiates Phase 2b 51 Immunicon Corporation 51 Poniard Pharmaceuticals 51 Ingenium Pharmaceuticals AG 51 Receives SFDA Approval 51 Inc. NASDAQ MBLX 51 IOMAI 50 SSRX 50 BioProcessors 50 Calls Purchased 50 Commercialize Novel 50 ICOS Vision Systems 50 OTCBB DORB 50 Possible Bearish Harami Pattern 50 Genelabs Technologies 50 HERTZ GLOBAL 50 CITZ 50 Unipath 50 Inc. Nasdaq COLY 50 Small Molecule Drug 50 ANIK 50 Nasdaq RXII 50 Aestus Therapeutics 50 Anika Therapeutics 50 Microbia Precision Engineering 50 Dara BioSciences 50 Q1 Loss Narrows 50 PBIO 50 3X AS TRADERS 50 ViOptix Inc. 50 Achieves ISO # 50 Confirmatory Phase 50 Aileron Therapeutics 50 Novartis Femara letrozole 50 NYSE AMEX IBIO 50 AcelRx Pharmaceuticals 50 #.#X ABOVE AVERAGE VOLUME 50 Polyvinyl Alcohol 50 Puts Sold 50 introduced NEUGENE 50 Commences Phase 50 Teva Provides Update 50 OFLX 50 NGPS 50 fluorinated carbohydrate mimics 50 INTERNATIONAL THE TREND 50 Crosses Above 50 CAPITAL INC. 50 Settles Patent Dispute 50 Kun Run 50 Singapore Bourse Change 50 Intelerad Medical 50 Inflazyme Pharmaceuticals Ltd. 50 Terminate Merger Agreement 50 RHHBY 50 RELEASES ITS QUARTERLY NUMBERS 50 Porvair plc 50 Caprion Pharmaceuticals 50 CRUCELL 50 RU EEU EUROPE ASIA 50 CancerVax Corporation 50 ASTRAZENECA 50 Drew Fromkin President 50 CTIG 50 BIIB BIIB 50 Enrolls First 50 CO INC 50 Interferon beta 1a 50 Nasdaq MYRX 50 And Finerman Own 50 Steven Tregay 50 Founding Scientist 50 BioTherapeutics 50 NASDAQ POSS 50 LEVEL OF EFFICIENCY 50 Signs License Agreement 50 ActivBiotics 50 MSCRAMM R 50 Submits Biologics License Application 50 Maintains Hold Rating 50 Acrux Limited 50 SVP Exercises Options 50 PRN CORRECTION 50 Presents Preclinical 50 Almac Sciences 50 #/#-# KEYWORD MASSACHUSETTS INDUSTRY 50 Envirokare Tech Inc. 50 SHARES COULD POTENTIALLY PULLBACK 50 CALPINE 50 Anticancer Drug 50 MRNA 50 INDICATED HIGHER 50 Finerman Firm 50 CoreSpine Technologies 50 Cardiovasc 50 Myriad Genetics Inc 50 Lentigen Corporation 50 CORP. ANNOUNCES 50 Cytokine PharmaSciences 50 Vitro Technologies 50 ARCA biopharma Inc. 50 Tissue Repair 50 Lentiviral 50 Graftech International 50 Generex Biotech 50 ISTODAX ® 50 Genitrix 50 SIGNING LOW OF 50 MHLD 50 ViaCord R 50 SHARES DROP 50 MANAGEMENT CHANGES SOURCE 50 Miravant Medical Technologies 50 Metrologic Instruments 50 expanded autologous cellular 50 Irl Nucleus 50 BRUKER 50 HP Acthar R 50 CTRX 50 Nasdaq DIGE News 50 CeNeS Pharmaceuticals 50 Ondansetron Injection 50 ViroPharma NASDAQ VPHM 50 MDS MDS 50 IDIX 50 KAI Pharmaceuticals 50 Idera Pharmaceuticals Inc 50 Geriatr 50 UPTREND CALL 50 developing Bicifadine serotonin 50 ProCyte Corporation 50 SiEnergy Systems 50 Retains CCG Investor Relations 50 Resigns Quick Facts 50 Microfluidics International 50 GMPM 50 Files Patent Application 50 Obtains Exclusive Rights 50 InVivo Therapeutics Holdings 50 NASDAQ CERS 50 Tripos Discovery Research 50 Boehringer Ingelheim Pharma 50 Biomarker Study 50 Nasdaq CGEN 50 Q2 Profit Decreases 50 Avantium Technologies 50 YESTERDAY 'S RALLY OF 50 Xl Capital 50 Vantia Therapeutics 50 Kendro Laboratory Products 50 Ivivi Technologies 50 BioSante Pharmaceuticals Announces 50 Braintree Laboratories 50 Impax Laboratories IPXL 50 Neuroptix 50 JPT Peptide Technologies 50 Modular Genetics 50 EPT Disclosure BHP Billiton 50 Shareholders Approve Acquisition 50 Panacea Pharmaceuticals Inc. 50 Open Monoclonal 50 Ondansetron Orally Disintegrating Tablets 50 THE TREND CONTINUES DOWN 50 IGI Laboratories 50 Stuart Schoenmann 50 OTCBB CHKT 50 Completes Previously Announced 50 Biovitrum AB 50 AMEX MRM 50 Vipin Garg 50 Moving Average Crossover Alert 50 Gary Restani 50 SagaX 50 MINRAD 50 PHARM 50 ARM HOLDINGS 50 #mg/#mg 50 INSM 50 Sirion Therapeutics 50 HaptoGuard 50 bevacizumab Avastin R 50 AquaMed Technologies Inc. 50 Inc. Nasdaq OXGN 50 Array Biopharma 50 Orthovita VITA 50 HuMax 50 CYTR 50 Tacere 50 & MARKETING INDUSTRY 50 Lars Ekman 50 plc ELN 50 STOCK RISES #.# 50 Xenogen Corporation 50 Sangamo BioSciences 50 Daxor Corporation 50 NSPH 50 LS Starrett Company 50 Tst 50 Frequency Control 50 Therapeutic Competitors 50 Jörn Aldag President 50 COLLABORATION WITH 50 Antisoma plc 50 GLAXOSMITHKLINE 50 BIOPHARMACEUTICALS 50 Plethora Solutions Holdings 50 Capsulution 50 Quinton Cardiology Systems 50 LIFC 50 Extended Release tablets 50 mTCR 50 Chiral Technologies 50 AquaMed 50 Kreido Biofuels 50 AGY Therapeutics 50 Oxytrol R 50 SHPI 50 Vitaflo Scandinavia AB 50 PTIL 50 Excelsyn 50 Sygen International 50 Inc. Nasdaq AMGN 50 platform HDL Mimetic 50 CIMYM 50 Bearish Speculation 50 BENETTON 50 Combination REOLYSIN R 50 EMRG POL 50 Completes Asset 50 AVEO Pharmaceuticals Inc. 50 Grainger WW 50 SPECULATE ON HIGHER PRICES 50 NASDAQ DSCO 50 FDA Approvals 50 Arpida SWX ARPN 50 HP Acthar ® 50 VOLUME WATCH FOR PULLBACK 50 Eurand NV EURX 50 M.D. Ph.D. 50 Alnylam Pharmaceuticals Inc 50 NASDAQ CALP 50 R Custom NX 50 OTCBB EVSC 50 STENT 50 Orthopaedic Synergy 50 PHST 50 Abviva Inc. 50 Sue MacLeman 50 Announces Postponement 50 Backs FY# Outlook 50 Gastroenterol 50 Terminates Agreement 50 NEXM 50 NovaDel Pharma 50 AMEX ISV 50 Announces Recapitalization 50 Apitope 50 Memry Corporation 50 WILLIS GROUP 50 NASDAQ MNTA 50 FALLS BELOW 3 50 Bioservices 50 NASDAQ PARD 50 MOVIPREP R 50 About Crucell Crucell 50 DUKE ENERGY 50 IIROC Halt 50 Canaccord Genuity Reiterates Buy 50 Initiates Quarterly Dividend 50 Pressure BioSciences 50 treat chronic sinusitis 50 Oncology Compounds 50 TSRX 50 Hsp# Inhibitor 50 ANNOUNCES ACQUISITION OF 50 ARIUS Research 50 http:/www.Send2Press.com SOURCE 50 Ardea Biosciences 50 Agouron Pharmaceuticals 50 LITHIA MOTORS 50 Materialise NV 50 LOUISMO 50 WEEK LOW 50 Receive Milestone Payment 50 CRWEWallstreet.com Stock Report 50 Ascent Therapeutics 50 ImmunoCellular Therapeutics 50 Nasdaq CRXL 50 Receives Requisite Consents 50 Hainan Helpson Medical 50 Finalizes Purchase 50 AB Wilh 50 Signs Definitive Merger Agreement 50 RIO RIO TINTO 50 Endo Pharmaceutical 50 annuloplasty product 50 Chronogen 50 Retains CCG Elite 50 Settle Patent Litigation 50 Kyto Biopharma Inc. 50 Submits IND 50 VISTEON 50 LCRY 50 Presidio Pharmaceuticals 50 dedicated CHAT ROOM 50 NSTK 50 Protalex Inc. 50 Antisense Pharma GmbH 50 DETECTS BEARISH ENGULFING PATTERN 50 Subsidiary Agrees 50 Optical Sensors 50 OTCBB IBPM 50 Inc.John 50 NeoStrata Company 50 Specialty Enzymes 50 INTERIM RESULTS FOR 50 Pervasis Therapeutics 50 Nasdaq BPUR 50 Seabright Insurance 50 RepliCel 50 Enzo Biochem NYSE ENZ 50 IIROC Resume 50 BRANDS INC. 50 Coil Tubing Technology 50 Stockwire.com OTC 50 CyDex Pharmaceuticals 50 Pharmacyclics Inc. 50 Regains Compliance With 50 FNET 50 Grp Inc